The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia

Abstract

Our retrospective chart review suggests that patients with SCHZ experience similar rates of psychiatric symptoms on and off antiviral therapy. Despite limitations and constraints of the methods, our data suggest that SCHZ is not a contraindication to antiviral therapy for HCV.